Efficacy evaluation of heat-sensitive moxibustion for chemotherapy symptoms of large intestine cancer.
- Author:
Zhiping LI
;
Zhi ZHENG
;
Lijun WANG
;
Weiyun XIAO
;
Jiquan ZENG
;
Jing HAO
;
Rixin CHEN
;
Dingyi XIE
- Publication Type:Journal Article
- MeSH: Aged; Antineoplastic Agents; adverse effects; therapeutic use; Antineoplastic Combined Chemotherapy Protocols; adverse effects; therapeutic use; Colorectal Neoplasms; drug therapy; Drug-Related Side Effects and Adverse Reactions; etiology; therapy; Female; Fluorouracil; adverse effects; therapeutic use; Humans; Intestine, Large; drug effects; Leucovorin; adverse effects; therapeutic use; Male; Middle Aged; Moxibustion; instrumentation; Organoplatinum Compounds; adverse effects; therapeutic use; Treatment Outcome
- From: Chinese Acupuncture & Moxibustion 2015;35(10):1010-1013
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo analyze and evaluate the clinical efficacy of heat-sensitive moxibustion for symptoms of large intestine cancer.
METHODSSixty patients with large intestine cancer were randomly divided into an observation group and a control group, 30 cases in each one. FOLFOX chemotherapy regimen was used in the two groups,and heat-sensitive moxibustion was added in the observation group. The acupoints were Zusanli(ST 36), Sanyinjiao (SP 6) Xuehai (SP 10) and Geshu (BL 17), etc. The treatment was applied once a day,five-day treatment as one course. Four courses were required. The reaction rates of uncomfortable symptoms by the Chinese version of the M. D. Anderson symptom inventory (MDASI-C) scale and clinical effects were analyzed and evaluated in the two groups.
RESULTSAfter treatment, the MDASI-C reaction rate of uncomfortable symptoms in the observation group was 50.4% which was lower than 53.3% in the control group (P < 0.05). The total effective rate of symptom improvement in the observation group was 83.3% (25/30), which was higher than 60.0% (18/30) in the control group (P < 0.05).
CONCLUSIONHeat-sensitive moxibustion can improve symptoms of chemotherapy for large intestine cancer.